Inventor · disambiguated record
Lieming Ding
Also filed as: DING LIEMING
14 granted patents·37 pending applications·18 citations·filing 2009–2024
86Inventor score
Files withBETTA PHARMACEUTICALS CO LTD46WANG YINXIANG2BETA PHARMA INC1HANGZHOU VIROMAB BIOTECH CO LTD1HU SHAOJING1
Top patents by PatentIndex Score
51 records- 0189US11365196B2FGFR inhibitor and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2018·Granted Jun 21, 2022·6 cites·33 claims
- 0280US8951959B2Glucagon-like peptide-1 analogues and uses thereofWANG YINXIANG·Filed 2011·Granted Feb 10, 2015·8 cites·6 claims
- 0376US11845762B2Compound functioning as bromodomain protein inhibitor, and compositionBETTA PHARMACEUTICALS CO LTD·Filed 2022·Granted Dec 19, 2023·0 cites·8 claims
- 0473US8822482B2Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereofWANG YINXIANG·Filed 2009·Granted Sep 2, 2014·2 cites·35 claims
- 0573US2025223286A1Immunomodulators, compositions and methods thereofBETTA PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0672US11053238B2Benzimidazole derivatives, preparation methods and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2017·Granted Jul 6, 2021·1 cites·33 claims
- 0764US9487570B2Glucagon like peptide analogs, composition, and method of useHU SHAOJING·Filed 2010·Granted Nov 8, 2016·1 cites·6 claims
- 0860US2024352053A1Salt and crystal form of egfr inhibitor, and composition and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0960US2025051301A1Mutant idh1 and idh2 inhibitor and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1060US2025361241A1Hpk1 inhibitor and medical use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1160US2025223300A1Macrocyclic compound and pharmaceutical composition and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1258US12043622B2Crystal form of compound for inhibiting the activity of CDK4/6 and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Granted Jul 23, 2024·0 cites·9 claims
- 1358US2025042853A1Bicyclic compound and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1458US2024342169A1Use of ensartinib or salt thereof in treatment of disease carrying met 14 exon skipping mutationBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1558US2025304690A1Therapeutic agent comprising multispecific antibody and use thereof in tumor therapyHANGZHOU VIROMAB BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1657US2025154149A1Pharmaceutical composition and method for preparing active ingredient compound thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1756US12187713B2Immunomodulators, compositions and methods thereofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Granted Jan 7, 2025·0 cites·20 claims
- 1856US9359370B2Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereofBETA PHARMA INC·Filed 2014·Granted Jun 7, 2016·0 cites·13 claims
- 1955US2024336594A1Six-membered aryl or heteroaryl amides, and composition and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2055US2024246994A1Polymorph Of Imidazolidinone Compound, Preparation Method Therefor And Use ThereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2155US2024299380A1Application of compound in preparation of drug for treating myelofibrosis and related symptoms/signs thereof, and use of compoundBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2255US2023321100A1Cd73 inhibitor and application thereof in medicineBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2354US9688687B2Polymorphic forms of icotinib phosphate and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Jun 27, 2017·0 cites·25 claims
- 2454US2024327518A1Anti-pd-l1 nanobody and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2553US11466034B2Compound functioning as bromodomain protein inhibitor, and compositionBETTA PHARMACEUTICALS CO LTD·Filed 2018·Granted Oct 11, 2022·0 cites·22 claims
- 2653US9611272B2Polymorphic forms of icotinib and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Apr 4, 2017·0 cites·20 claims
- 2753US2024383974A1Bispecific antibody and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2853US2021340142A1Salt form and crystal form of novel azatricyclic compound and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 2952US2023339882A1Shp2 inhibitor and composition and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3051US2023391779A1Bicyclic compounds, compositions and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3151US2023192705A1Shp2 inhibitors, compositions and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3250US2022227796A1Egfr inhibitors, compositions and methods there ofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3350US2023203055A1Fused ring compound and application thereof in medicineBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3450US2023133169A1Egfr inhibitor, composition, and method for preparation thereofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3550US2024174681A1Salt and crystalline forms of fgfr4 inhibitor and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3650US2023053342A1Imidazolidinone compound, preparation method therefor and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3749US2023062486A1Kras g12c inhibitor and pharmaceutical use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3849US2023131025A1Quinolyl phosphine oxide compound, and composition and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3949US2022402948A1Egfr inhibitor, composition and preparation method thereforBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 4047US9505774B2Polymorphic forms of icotinib maleate and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2014·Granted Nov 29, 2016·0 cites·24 claims
- 4147US2022064196A1EGFR Inhibitors, Compositions and Methods ThereofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 4245US2022259235A1EGFR Inhibitor, Composition, and Preparation Method ThereforBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 4344US2021395256A1Tyrosine kinase inhibitors, compositions and methods there ofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 4444US2023219890A1Bicyclic compounds and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 4543US2023219956A1Quinazoline compound and pharmaceutical application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 4643US2021269440A1Immunomodulators, compositions and methods thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 4742US2021300909A1Immunomodulators, compositions and methods thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 4842US2022119411A1Immunomodulators, compositions and methods thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 4942US2022002307A1Fgfr4 inhibitor and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 5040US2021040118A1Immunomodulators, compositions and methods thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lieming Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →